利用寡核酸结构,对人类碳酸无水酶进行强有力的多价值抑制
Eslam M Abbass1,2, Federico Ladu1,3, Justine Mansot1
1IBMM, University of Montpellier, CNRS, ENSCM Montpellier France michael.smietana@umontpellier.fr jean-yves.winum@umontpellier.fr.
RSC medicinal chemistry
|March 4, 2026
概括
研究人员使用DNA平台开发了新型碳酸酶抑制剂 (CAI). 一种双价二硫胺联体显示,对与瘤相关的碳酸无水酶IX的功效增加了3.5倍.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 奥利冈核酸治疗药物 治疗药物
背景情况:
- 碳酸酶抑制剂 (CAI) 对于治疗各种疾病至关重要.
- 开发多价值抑制剂可以提高功效和选择性.
- 寡核酸为呈现多种药提供了一个多功能平台.
研究的目的:
- 设计和合成使用寡核酸的新型多价值碳酸酶抑制剂.
- 探索寡核酸作为酶抑制可编程平台的潜力.
- 评估合成的CAI的强度和多价值效应.
主要方法:
- 单链寡核酸与基因部分的固体相合成.
- 制备亚酸功能化碳酸酶抑制剂衍生物 (氨酸和硫胺).
- 催化亚酸环添加 (CuAAC) 将抑制剂与寡核酸结合,创建单价到四价架构.
主要成果:
- 合成了17个基于寡核酸的CAI库,具有不同的价值.
- 双价二硫胺联体19显示出显著的多价效应效应.
- 结合物19显示对人类碳酸酶IX (hCA IX) 的功效增加了3.5倍,Ki为69nM.
结论:
- 寡核酸作为有效的可编程平台,用于开发多价值酶抑制剂.
- 模块化方法允许空间控制的药理体呈现.
- 这一策略为创造强效和选择性的CAI开辟了新的途径,特别是针对hCA IX等与瘤相关的异型.
相关概念视频
Enzyme Inhibition
72.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
72.3K
Allosteric Proteins-ATCase
4.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
Inhibitors of Bacterial DNA Synthesis
125
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
125
Inhibitors of Viral Protein Synthesis
57
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
57


